Monitoring communicable diseases throughout South Africa and the African continent
Communicable diseases outbreak, and epidemic monitoring and response
Collect, analyse and interpret relevant data on communicable diseases

NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES

The national institute for communicable diseases (NICD)

Is a resource of knowledge and expertise in regionally relevant communicable diseases to the South African Government, to SADC countries and the African continent.

The NICD offers a variety of training programmes in the different areas of public health, including Field Epidemiology Training

The Communicable diseases communiqué is published on a monthly basis for the purpose of providing up-to-date information on communicable diseases in South Africa. 

World Malaria day highlights the global efforts to control malaria and celebrates the gains that have been made. This year’s theme 2019 is
End Malaria for Good.’

Latest News

APRIL COMMUNIQUE
Latest Information on Communicable Diseases in South Africa
Read More

LATEST SCIENTIFIC PUBLICATIONS

Age at antiretroviral therapy initiation and cell-associated HIV-1 DNA levels in HIV-1-infected children
Age at antiretroviral therapy initiation and cell-associated HIV-1 DNA levels in HIV-1-infected children
The latent viral reservoir is the major obstacle to achieving HIV remission and necessitates life-long antiretroviral therapy (ART) for HIV-infected individuals. Studies in adults and children have found that initiating ART soon after infection is associated with a reduction in the size of the HIV-1 reservoir. Here we quantified cell-associated HIV-1 DNA in early-treated but currently older HIV-infected children suppressed on ART.
Analysis of risk factors associated with hepatocellular carcinoma in black South Africans: 2000-2012
Analysis of risk factors associated with hepatocellular carcinoma in black South Africans: 2000-2012
The aims of this study were to determine the prevalence of risk factors associated with hepatocellular carcinoma (HCC) in black adult South Africans and to estimate the size of the associated risks
Common variation in NLRP3 is associated with early death and elevated inflammasome biomarkers among advanced HIV/TB co-infected patients in Botswana
Common variation in NLRP3 is associated with early death and elevated inflammasome biomarkers among advanced HIV/TB co-infected patients in Botswana
Elevated inflammation is associated with early mortality among HIV/tuberculosis (TB) patients starting antiretroviral therapy (ART); however, the sources of immune activation are unclear. We hypothesized that common variation in innate immune genes contributes to excessive inflammation linked to death. As single nucleotide polymorphisms (SNPs) in inflammasome pathway genes can increase risk for inflammatory diseases, we investigated their association with early mortality among a previously described cohort of HIV/TB patients initiating ART in Botswana.
Previous
Next
Close Menu